Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing,…
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
Scaleup Europe, a public-private fund with a $5.7 billion target, made its first investment by backing Finnish…
The app lets users share disappearing photos with their friends that can be viewed only once and…
The report suggests that greater exposure will not resolve the unease around the technology, nor reduce public…
LinkedIn says hiring is down 20% since 2022, but blames higher interest rates — not AI —…
Equal AI said that its AI-powered call assistant now has over a million monthly active users.
Siri’s AI overhaul may have grabbed the headlines at WWDC, but some of Apple’s most useful AI…
